Applying Recent Advances in Psoriasis to Clinical Practice: Piecing the Puzzle Together to Optimize the Patient Experience

FREE CME

CLICK HERE FOR More Information & REGISTRATION

PROGRAM OVERVIEW

Psoriasis is an immune-mediated chronic skin condition that also has effects on other systems of the body and is associated with several other debilitating conditions, such as diabetes, heart disease, and mental disorders. Psoriasis represents a huge healthcare burden, and afflicted patients report high economic costs and a poor quality of life. An improved understanding of the pathophysiology of the disease has led to the development and approval of several novel therapies, and the treatment landscape has been constantly evolving. Given that new evidence continues to be reported and that therapy recommendations keep changing, it is paramount that dermatologists and other healthcare clinicians are up-to-date on recent safety and efficacy outcomes and are able to provide individualized care for diverse patients with complex comorbid conditions. Current clinical practice, however, has been lagging behind, and many clinicians face challenges in effectively employing multidisciplinary and patient-centered approaches to improving patient outcomes.

FACULTY

April W. Armstrong, MD, MPH
Professor of Dermatology
Associate Dean of Clinical Research
Director, Psoriasis Program
University of Southern California
Los Angeles, California

PHYSICIAN CONTINUING MEDICAL EDUCATION ACCREDITATION STATEMENT

Purdue College of Pharmacy is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Purdue College of Pharmacy designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PROVIDER STATEMENT

Co-provided by Purdue College of Pharmacy and Integrity Continuing Education, Inc.

SUPPORTER ACKNOWLEDGEMENT

This activity is supported by an educational grant from Novo Nordisk.